<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="authorization for the prophylaxis and early treatment of CanL to" exact="domperidone" post="(LeisguardÂ®, Laboratorios del Dr. Esteve, Barcelona, Spain) [8], an"/>
 <result pre="8Gomez-OchoaP, CastilloJA, GasconM, ZarateJJ, AlvarezF, et al. (2009) Use of" exact="domperidone" post="in the treatment of canine visceral leishmaniasis: a clinical"/>
 <result pre="4719â€&quot;4725.11447143 42PerezLE, ChandrasekarB, SaldarriagaOA, ZhaoW, ArteagaLT, et al. (2006) Reduced" exact="nitric oxide" post="synthase 2 (NOS2) promoter activity in the Syrian hamster"/>
 <result pre="and -resistant strains of Leishmania donovani that correlates with inducible" exact="nitric oxide" post="synthase activity and IL-4 generation: evidence for mixed Th1-"/>
 <result pre="of human visceral leishmaniasis: progressive disease and impaired generation of" exact="nitric oxide" post="in the face of a prominent Th1-like cytokine response."/>
 <result pre="in dogs experimentally infected with Leishmania infantum and treated with" exact="meglumine" post="antimoniate. Vet Parasitol84: 33â€&quot;47.10435789 80LivakKJ, SchmittgenTD (2001) Analysis of"/>
</results>
